富祥药业：公司他唑巴坦产品通过巴西国家卫生监督局GMP认证

Core Viewpoint - Fuxiang Pharmaceutical has obtained GMP certification from the Brazilian National Health Surveillance Agency for its chemical raw material, Tazobactam, enabling the product's entry into the Brazilian market and laying the groundwork for further international market expansion [1] Summary by Categories - Certification Achievement - The company received GMP certification for Tazobactam, which is a significant milestone for its international operations [1] - Market Expansion - This certification allows the company to enter the Brazilian market, indicating potential growth opportunities in South America [1] - Business Risks - The international raw material pharmaceutical business is subject to various influencing factors, which introduces uncertainty [1]